Immucell (ICCC) Operating Expenses (2010 - 2026)
Immucell's (ICCC) quarterly Operating Expenses came in at $3.0 million in Q4 2025, up 34.29% YoY from $2.2 million in Q4 2024, and up 26.68% on a QoQ basis from $2.3 million in Q3 2025.
Immucell (ICCC) Operating Expenses (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Operating Expenses data on file, last reported at $3.0 million in Q4 2025.
- Quarterly Operating Expenses rose 34.29% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.8 million (up 2.24% YoY) and the FY2025 annual result came in at $9.8 million, up 2.24% from the prior year.
- Operating Expenses climbed to $3.0 million in Q4 2025, from $2.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.0 million in Q4 2025 to a low of $1.9 million in Q2 2021.
- A 5-year average of $2.4 million and a median of $2.3 million in 2023 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 34.29% in 2025, down 14.09% in 2025.
- Tracing ICCC's Operating Expenses over 5 years: stood at $2.4 million in 2021, then increased by 8.72% to $2.6 million in 2022, then slipped by 6.66% to $2.5 million in 2023, then slipped by 9.82% to $2.2 million in 2024, then soared by 34.29% to $3.0 million in 2025.
- The last three Operating Expenses figures came in at $3.0 million (Q4 2025), $2.3 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 502,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 502,288.00 |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 2.56 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 2.46 Mn |
| Jun 30, 2022 | 2.33 Mn |
| Mar 31, 2022 | 2.53 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 1.86 Mn |
| Mar 31, 2021 | 1.98 Mn |